Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?
暂无分享,去创建一个
D. Consonni | E. Orsi | A. Cortelezzi | E. Orlandi | A. Iurlo | V. Grancini | N. Orofino | M. Sciumè | C. Elena | D. Cattaneo | V. Resi | C. Bucelli